Literature DB >> 29191046

Cost-effectiveness associated with amyotrophic lateral sclerosis: some questions and answers pending.

Giuseppe Fiorentino1, Antonio M Esquinas2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29191046     DOI： 10.1080/21678421.2017.1408126

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN： 2167-8421            Impact factor:   4.092


× No keyword cloud information.
  2 in total

1.  The economic burden of amyotrophic lateral sclerosis: a systematic review.

Authors:  K Achtert; L Kerkemeyer
Journal:  Eur J Health Econ       Date:  2021-06-18

2.  Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany.

Authors:  Erik Schönfelder; Alma Osmanovic; Lars Hendrik Müschen; Susanne Petri; Olivia Schreiber-Katz
Journal:  Orphanet J Rare Dis       Date:  2020-06-12       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.